TGFB1 and hematopoietic and lymphoid system neoplasm: To explore the biological processes associated with TGFB1 expression in blood cancers, we performed differential expression analysis between the top 30% TGFB1 expression subgroup and bottom 30% TGFB1 expression subgroup in each blood cancer type.